HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$46.50
Day range
$46.02 - $50.63
Year range
$7.79 - $65.60
Market cap
2.64B USD
Avg Volume
670.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 439.00K | -82.56% |
Operating expense | 17.67M | 174.42% |
Net income | -28.06M | -142.56% |
Net profit margin | -6.39K | -1,290.71% |
Earnings per share | -0.51 | -104.00% |
EBITDA | -35.33M | -130.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 658.03M | 88.16% |
Total assets | 695.02M | 79.66% |
Total liabilities | 38.92M | 2.67% |
Total equity | 656.10M | — |
Shares outstanding | 52.48M | — |
Price to book | 3.71 | — |
Return on assets | -12.93% | — |
Return on capital | -13.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -28.06M | -142.56% |
Cash from operations | -2.23M | 80.95% |
Cash from investing | 12.67M | 120.62% |
Cash from financing | 1.65M | -97.09% |
Net change in cash | 12.09M | 173.06% |
Free cash flow | 6.40M | 177.41% |
About
Founded
2017
Website
Employees
76
